Literature DB >> 15223794

Ex vivo adenovirus-mediated gene transfer to corneal graft endothelial cells in mice.

Ying Qian1, Fee-Lai Leong, Andrius Kazlauskas, M Reza Dana.   

Abstract

PURPOSE: Genetic modulation of donor tissue before corneal transplantation may have the potential to modulate alloimmunity and/or to prevent corneal endothelial cell death. This study was conducted to optimize adenovirus-mediated gene transfer to donor corneal endothelium and to delineate the kinetics of marker gene expression in syngeneic and allogeneic corneal grafts.
METHODS: BALB/c mouse corneas were incubated with replication-deficient adenovirus encoding green fluorescent protein (GFP) or empty vector ex vivo at a dose of 6 x 10(7) or 6 x 10(6) PFU at temperatures of 4 degrees C or 37 degrees C. After ex vivo infection, the donor corneas were transplanted orthotopically to BALB/c or C57BL/6 recipients. After transplantation, localization of GFP in the grafts was determined in cryosections of enucleated eyes, and GFP expression in the grafts was visualized in vivo by using epifluorescence microscopy over 12 weeks. All grafts were evaluated clinically by slit lamp biomicroscopy.
RESULTS: GFP expression was found to be restricted to the corneal endothelium. In vivo expression of GFP in syngeneic corneal grafts was demonstrated for up to 12 weeks. Syngeneic grafts incubated with the vector at 4 degrees C exhibited a more extensive and longer duration of expression of green fluorescence than grafts incubated at 37 degrees C. Moreover, the syngeneic grafts infected at 4 degrees C maintained their transparency, whereas those infected at 37 degrees C displayed a high degree of opacity. Corneal allogeneic grafts infected with a low dose of the vector displayed longer GFP expression and graft survival than the allogeneic grafts infected with a high dose of the viral vector.
CONCLUSIONS: Adenoviral vector can selectively and efficiently deliver exogenous gene(s) to the endothelium of corneal grafts during hypothermic organ preservation. Gene expression is retained in vivo in corneal syngeneic grafts for longer periods than are allogeneic grafts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223794     DOI: 10.1167/iovs.03-0901

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases?

Authors:  T Ritter; N Gong; U Pleyer
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

Review 2.  Gene delivery to cornea.

Authors:  Jinsong Hao; S Kevin Li; Winston W Y Kao; Chia-Yang Liu
Journal:  Brain Res Bull       Date:  2009-06-26       Impact factor: 4.077

3.  In vitro adenovirus mediated gene transfer to the human cornea.

Authors:  C F Jessup; H M Brereton; D J Coster; K A Williams
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

4.  Functional Foxp3+ CD4+ CD25(Bright+) "natural" regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection.

Authors:  Anthony B Nesburn; Ilham Bettahi; Gargi Dasgupta; Alami Aziz Chentoufi; Xiuli Zhang; Sylvaine You; Naoyuki Morishige; Andrew J Wahlert; Donald J Brown; James V Jester; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

5.  Ex vivo transfer of Smad7 decreases damage to the corneal endothelium after penetrating keratoplasty.

Authors:  Toshinari Funaki; Nobuyuki Ebihara; Akira Murakami; Atsuhito Nakao
Journal:  Jpn J Ophthalmol       Date:  2008-07-27       Impact factor: 2.447

Review 6.  Gene therapy in corneal transplantation.

Authors:  Yureeda Qazi; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

7.  The use of adenoviral vectors in gene therapy and vaccine approaches.

Authors:  Natália Meneses Araújo; Ileana Gabriela Sanchez Rubio; Nicholas Pietro Agulha Toneto; Mirian Galliote Morale; Rodrigo Esaki Tamura
Journal:  Genet Mol Biol       Date:  2022-10-07       Impact factor: 2.087

Review 8.  Strategies for local gene therapy of corneal allograft rejection.

Authors:  Pho Nguyen; Samuel C Yiu
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.